BMRA
Biomerica, Inc.
BMRA trails on the overall score without a compensating advantage in the available component scores.
UNH
UnitedHealth Group Incorporated
UNH has the edge over BMRA overall, supported by stronger fundamentals and lower modeled downside.
BMRA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
BMRA's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
BMRA PE Valuation
BMRA has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
BMRA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect BMRA's losses to grow, with revenue declining.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
BMRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.67 | -$0.15 |
| Q2 2026 | -$1.30 | +$0.86 |
| Q1 2026 | -$1.45 | +$0.87 |
| Q4 2025 | -$1.49 | +$1.23 |
| Q3 2025 | -$1.52 | +$1.44 |
| Q2 2025 | -$2.16 | +$0.72 |
| Q1 2025 | -$2.32 | +$0.64 |
| Q4 2024 | -$2.72 | +$0.32 |
BMRA is still losing money, but far less than before: $1.67 per share over the past year, against $4.96 at its worst in mid-2021.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over BMRA on earnings quality, reporting a profit while its opponent remains loss making.
BMRA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3M | -8.3% |
| Q2 2026 | $875K | +17% |
| Q1 2026 | $987K | -12% |
| Q4 2025 | $1.2M | -26% |
| Q3 2025 | $1.4M | -24% |
| Q2 2025 | $749K | -33% |
| Q1 2025 | $1.1M | +10% |
| Q4 2024 | $1.6M | +4.4% |
BMRA's revenue has slid since its 2022 peak: $1M last quarter, down 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -97% | -16 points |
| Q2 2026 | -175% | +34 points |
| Q1 2026 | -132% | -23 points |
| Q4 2025 | -113% | -53 points |
| Q3 2025 | -81% | -5.3 points |
| Q2 2025 | -209% | -72 points |
| Q1 2025 | -108% | +89 points |
| Q4 2024 | -61% | +42 points |
BMRA's operating margin was −97% last quarter, down 16 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over BMRA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over BMRA on profitability, with a higher operating margin.
BMRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$802K | -$534K |
| Q2 2026 | -$912K | -$251K |
| Q2 2025 | -$661K | +$407K |
| Q2 2024 | -$1.1M | -$105.2K |
| Q1 2024 | -$1.8M | -$70.4K |
| Q4 2023 | -$848K | +$389.7K |
| Q3 2023 | -$1.7M | -$88.1K |
| Q2 2023 | -$962.8K | +$3.3M |
BMRA has burned cash in almost every quarter: −$4M over the past year, against −$4M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over BMRA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BMRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.5% | +286K shares |
| 1 year | +43% | +999K shares |
| 3 years | +86% | +1.5M shares |
| 5 years | +121% | +1.8M shares |
| Available history | +169% | +2.1M shares |
BMRA has 3M diluted shares, up 43% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over BMRA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
BMRA Net Leverage
BMRA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
BMRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.0 | Neutral |
| Stochastic | 10.9 | Oversold |
BMRA's weekly RSI is 34 (neutral) and its Stochastic is 11 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
BMRA PE vs Healthcare Sector
BMRA has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
BMRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.81 | 28% below |
| 20 week MA | $1.83 | 29% below |
| 50 week MA | $2.08 | 38% below |
| 100 week MA | $2.83 | 54% below |
| 200 week MA | $5.62 | 77% below |
BMRA is in a downtrend: it's below all five of its weekly moving averages, and 77% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over BMRA on trend strength, trading above more of its moving averages.
BMRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.6 | $39.8 | +84% |
| 2021 | $39.8 | $33.6 | -15% |
| 2022 | $33.6 | $29.7 | -12% |
| 2023 | $29.7 | $10.0 | -66% |
| 2024 | $10.0 | $2.52 | -75% |
| 2025 | $2.52 | $2.70 | +7.1% |
| 2026 YTD | $2.70 | $1.30 | -52% |
BMRA has finished lower in four of the last six years. It's down 52% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over BMRA on returns for 2026, with the stronger performance.